Evidence map›Paper›PMID 41345278›Full record

ArticleNature neuroscience2026

In vivo CRISPR screen reveals regulation of macrophage states in neuroinflammation.

Clara de la Rosa, Arek Kendirli, Seren Baygün, Franz Bauernschmitt, Anna S Thomann, Ilgin Kisioglu, Daniela Beckmann, Yves Carpentier Solorio, Veronika Pfaffenstaller, Yi-Heng Tai and 10 more

Abstract read
In one paragraph

Article in Nature neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Multiple sclerosis: 2026 update.Free neuropathology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Clara de la Rosa *Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-1344-0844
Arek Kendirli *Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany. arek.kendirli@med.uni-muenchen.de.ORCID http://orcid.org/0000-0001-6888-9131
Seren BaygünInstitute of Experimental Haematology, Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University Munich, Munich, Germany.
Franz BauernschmittInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.
Anna S ThomannInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.ORCID http://orcid.org/0000-0001-6934-8839
Ilgin KisiogluInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.
Daniela BeckmannInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.
Yves Carpentier SolorioInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.
Veronika PfaffenstallerInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.
Yi-Heng TaiInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.
Niel MehraeinInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.
Paula SanchezInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.
Lena SpiethInstitute of Neuronal Cell Biology, Technical University Munich, Munich, Germany.
Lisa Ann GerdesInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.
Eduardo BeltranInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-7266-4098
Klaus DornmairInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.ORCID http://orcid.org/0000-0003-0342-5373
Mikael SimonsMunich Cluster of Systems Neurology (SyNergy), Munich, Germany.ORCID http://orcid.org/0000-0001-5329-192X
Anneli PetersInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-8259-2219
Marc Schmidt-SupprianInstitute of Experimental Haematology, Center for Translational Cancer Research (TranslaTUM), School of Medicine and Health, Technical University Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-8543-6166
Martin KerschensteinerInstitute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany. martin.kerschensteiner@med.uni-muenchen.de.ORCID http://orcid.org/0000-0003-4898-9383

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 239283807Deutsche Forschungsgemeinschaft (German Research Foundation) 259373024Deutsche Forschungsgemeinschaft (German Research Foundation) 408885537
6 · The paper itself

Abstract

Here we established an in vivo CRISPR screening pipeline using genetically editable progenitor cells to dissect macrophage regulation in mouse models of multiple sclerosis (MS). Screening over 100 cytokine receptors and signaling molecules identified interferon-γ, tumor necrosis factor, granulocyte-macrophage colony-stimulating factor and transforming growth factor-β as essential regulators of macrophage polarization in vivo. Single-cell transcriptomics confirmed that transferred progenitor cells generate all blood-derived CNS myeloid cell populations, enabling Perturb-seq analysis of cytokine actions in neuroinflammation. Combined with biosensor expression, our approach allows monitoring cytokine effects on myeloid cell migration, debris phagocytosis and oxidative activity in vivo. Comparative transcriptomic analyses revealed conserved neuroinflammatory cytokine signatures across myeloid populations, CNS compartments and species, elucidating cytokine cues shaping myeloid function in the cerebrospinal fluid and parenchyma of individuals with MS. This versatile pipeline thus provides a scalable framework for high-resolution analysis of macrophage states and uncovers the cytokine signals that underlie their regulation in MS and MS models.

Indexed as

Clustered Regularly Interspaced Short Palindromic RepeatsEncephalomyelitis, Autoimmune, ExperimentalMacrophagesMultiple SclerosisNeuroinflammatory DiseasesAnimalsCRISPR-Cas SystemsCytokinesHumansMiceMice, Inbred C57BLCytokines

Identifiers

PMID41345278
PMCPMC12880918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.